Cancer research has received a big boost in funding, thanks to a $5.1m partnership between CSIRO and GenesisCare and an $800,000 grant from the Leukaemia Foundation to Cancer Australia.
The 2017 winner of the Prime Minister's Prize for Science, Professor Jenny Graves AO, has been elected to the coveted National Academy of Sciences in the US.
According to Afnan Zafar, collaboration in the field of product development must follow a strict set of rules if firms really want to benefit from open innovation and boost their performance.
MRCF5 will focus on investing in early-stage medical research discoveries linked to MRCF members and recently completed its first close, raising $210m from investors.
With the support of the Victorian Government, Trajan Scientific and Medical plans to invest $2.4 million in the expansion of its Melbourne facility over the next three years.
The economic and scientific benefits to Australia's membership of major global science organisations have been outlined in a report by the Australian Academy of Science.
The award-winning concept addresses in situ monitoring of chemical composition in microscopic reaction systems on timescales previously inaccessible to nuclear magnetic resonance techniques.
Dow has successfully completed its separation from DowDuPont, becoming a more focused and streamlined materials science company in the process.
NanoString Technologies has announced a commercial agreement with Abcam for the manufacture and sale of antibodies specifically for use with NanoString's GeoMx Digital Spatial Profiler (DSP).
Serving science company Thermo Fisher Scientific has begun a collaborative project with Genovis, a provider of enzyme products for biological drug development, to develop end-to-end workflows for the preparation, characterisation and monitoring of novel and complex biotherapeutics using liquid chromatography-mass spectrometry (LC-MS).
The Australian Government has announced $3.4m to improve STEM equity in Australia and boost the participation of girls and women in STEM careers.
Thermo Fisher Scientific has entered into a definitive agreement to acquire Brammer Bio, a leader in viral vector manufacturing for gene and cell therapies, for US$1.7 billion in cash.
Researchers who have identified potential targets for new medicines for acute myeloid leukaemia and lupus have been named the winners of the 2018 GSK Discovery Fast Track Challenge.
The Australian Government is investing almost half a billion dollars to deliver cancer treatment, hospital infrastructure, mental health services and medical research projects in Victoria.